Omega Healthcare Investors Inc expected to post earnings of 32 cents a share - Earnings Preview

Omega Healthcare Investors,

30/04/2024 23:46

* Omega Healthcare Investors Inc  OHI.N   OHI  is expected
to show
a rise in quarterly revenue when it reports  results on May 2
for the period ending March 31 2024
    * The Hunt Valley Maryland-based  company is expected to
report a
6.2% increase in revenue to $231.64 million from $218.2 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Omega Healthcare
Investors Inc
is for earnings of 32 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 11
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Omega
Healthcare
Investors Inc is $32.50​, above​ its last closing price
of $30.41. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  0.66        0.67       0.68      Beat    1.4
 Sep. 30 2023  0.70        0.70       0.71      Beat    1.3
 Jun. 30 2023  0.69        0.68       0.74      Beat    8.3​
 Jan. 1 0001   0.60        0.60       0.66      Beat    9.1
 ​​Dec.                    0.71                         
 31 2022                                                
 Sep. 30 2022  0.75        0.74       0.76      Beat    2.5​
 Jun. 30 2022  0.73        0.73       0.76      Beat    4.1
 Mar. 31 2022  0.69        0.70       0.74      Beat    6.4
 This summary was machine generated April 30 at 22:46 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)